Fereydounnia Sara, Shadmehr Azadeh, Tahmasbi Alireza, Salehi Raha Shams
Physical Therapy Department, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.
Int J Ther Massage Bodywork. 2022 Mar 2;15(1):4-14. doi: 10.3822/ijtmb.v14i4.691. eCollection 2022 Mar.
Respiratory involvement is a common consequence of COVID-19; changes in cardiorespiratory parameters of these patients during respiratory rehabilitation program are very important. Previous studies showed that myofascial release therapy (MFRT) could affect the respiratory muscle and adjunct fascia.
The aim of this study was to evaluate the effects of MFRT techniques and respiratory physiotherapy, in comparison with respiratory physiotherapy alone, on improving cardiorespiratory parameter in patients with COVID-19.
A hospital affiliated to Tehran University of Medical Sciences in Tehran, Iran, from February to July 2021.
Fifty patients with COVID-19 participated in this study.
A single-blind, randomized control design.
The patients with COVID-19 randomly assigned to an intervention group who received respiratory physiotherapy combined with MFRT or a control group receiving respiratory physiotherapy alone.
Heart rate, systolic and diastolic blood pressure, respiration rate, oxygen saturation, chest expansion, and ease of breathing were assessed at baseline and after the first and third session of treatment. Dyspnea and fatigue perception and 6-minute walking were assessed at baseline and at the end of treatment. Patient's thoughts about the treatment were examined through the 4-point Likert scale.
The ANOVAs found significant time effect for ease of breathing, dyspnea perception (F = 32.33, < .01 and F = 11.72, < .01, respectively). Also significant time by group interaction was found for chest expansion at xiphoid level (F = 4.02, = .02).
The present study provided evidence that both programs could result in improving ease of breathing and dyspnea perception, although the inclusion of MFR techniques into a respiratory physiotherapy program did not result in better outcomes in cardiorespiratory function of patients with COVID-19.
呼吸系统受累是新型冠状病毒肺炎（COVID-19）的常见后果；这些患者在呼吸康复计划期间心肺参数的变化非常重要。先前的研究表明，肌筋膜放松疗法（MFRT）可影响呼吸肌和附属筋膜。
本研究旨在评估与单纯呼吸物理治疗相比，MFRT技术和呼吸物理治疗对改善COVID-19患者心肺参数的效果。
2021年2月至7月，伊朗德黑兰医科大学附属的一家医院。
50名COVID-19患者参与了本研究。
单盲随机对照设计。
将COVID-19患者随机分为接受呼吸物理治疗联合MFRT的干预组或仅接受呼吸物理治疗的对照组。
在基线、第一次和第三次治疗后评估心率、收缩压和舒张压、呼吸频率、血氧饱和度、胸廓扩张度和呼吸舒适度。在基线和治疗结束时评估呼吸困难和疲劳感以及6分钟步行距离。通过4点李克特量表检查患者对治疗的看法。
方差分析发现呼吸舒适度、呼吸困难感知有显著的时间效应（F分别为32.33，P <.01和F为11.72，P <.01）。剑突水平的胸廓扩张度也发现有显著的组间时间交互作用（F = 4.02，P =.02）。
本研究提供的证据表明，尽管将MFRT技术纳入呼吸物理治疗计划并未使COVID-19患者的心肺功能获得更好的结果，但这两种方案均可改善呼吸舒适度和呼吸困难感知。
